Discusses BGE-102 Clinical Results and Development Strategy for Cardiovascular and Retinal Disease May 8, 2026 12:30 PM ...
Enrollment proceeding in KOMODO-1 first-in-human clinical trial of BBI-940 $93 million in cash provides runway through expected clinical proof-of-concept readout for KOMODO-1 SAN DIEGO, May 08, 2026 ...
Enrollment proceeding in KOMODO-1 first-in-human clinical trial of BBI-940$93 million in cash provides runway through expected clinical ...
Peptide therapeutics require tailored ADME strategies to address stability, supporting more effective and reliable drug ...
Phase 1 dose-escalation trial on track; preclinical combination data with anti-PD-1 antibody demonstrates potential for ...
The Hearty Soul on MSN
Scientists have finally identified where gluten reactions begin
Something remarkable happens to the body of a person with celiac disease when they eat a piece of bread. Within hours, a ...
BGM0504 Achieves 19.3% Robust Weight Reduction, 16.5 Cm Waist Circumference Decrease, Significant SBP/DBP Improvements Of 22.9/12.9 Mmhg, And 70.7 Μmol/L Uric Acid Reduction Phase III Trial Meets ...
7d
University of Utah’s newest grads challenged to take risks, embrace weakness — and keep ‘showing up’
University of Utah hosts commencement exercises for Ccass of 2026. Bestselling "happiness" author Arthur Brooks delivers ...
The American Academy of Arts and Sciences announced its 2026 class on April 23, recognizing 25 UC-affiliated scholars, 23 UC ...
Scientists reveal how graphene toothbrushes eliminates bacteria without harming human cells, revolutionizing daily hygiene.
New research has shown that single blood vessel cells that appear in the earliest stages of lab-grown skin organoids have the ...
AT THE 2025 Prefontaine Classic, a sold-out crowd of 12,606 was treated to two profound demonstrations of human potential on a perfect July afternoon. First up was Beatrice Chebet. In the closing laps ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results